Abstract Library

#4283 Long-term efficacy and safety of peptide receptor radionuclide therapy (PRRT) in Japanese patients with unresectable neuroendocrine tumour: Japanese phase I and phase I/II extension study

Introduction: PRRT with 177Lu-DOTATATE has been approved in Japan according to Japanese phase I and Phase I/II clinical trials. Primary end point of these clinical studies was safety and response rate, therefore, long-term efficacy and safety of PRRT for Japanese patients with NET are uncertain.

Conference:

Presenting Author: Ichikawa Y

Authors: Kobayashi N, Ono H, Okubo N, Akahoshi K, Kudo A,

Keywords: Neuroendocrine tumour, Peptide receptor radionuclide therapy, Japanese patients,

#4093 Evaluation of the utility of group therapy as a mechanism of delivering facilitated psychosocial support to those with a neuroendocrine neoplasm diagnosis

Introduction: Anxiety, uncertainty and reduced psychosocial well-being have been reported in those with neuroendocrine neoplasms. There has been an increasing demand for facilitated psychosocial support from our UK community, that can outstrip capacity. There is evidence that group therapy can provide a cost- efficient and outcome- effective method of treatment: reducing wait times and improving accessibility. Group therapy is a term that can be applied to any kind of psychotherapy that is delivered to a group.

Conference:

Presenting Author: Hargreaves R

Authors: Jervis N, Winter K, Hargreaves R, Ellis C,

Keywords: Group Therapy, Unmet Needs, Psychosocial Support,

#3653 Neuroendocrine urological tumors – Experience of the medical oncology department of the hospital November 1st, 1954, in Oran (Algeria)

Introduction: Neuroendocrine tumors (NET) are mainly located in the digestive tract (85%) and the lung (10%). The other localizations are rare, notably at the urological tract with an uncertain prognosis. At diagnostic, these tumors are often in the metastatic stage. Their treatment is based on chemotherapy (platinum drug).

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Kaid M, Benabdellah H,

Keywords: neuroendocrine urological tumor, poor prognosis,

#3535 A case series and literature review of DIPNECH

Introduction: DIPNECH is characterised by bilateral carcinoids ≤0.5cm, tumorlets

Conference:

Presenting Author:

Authors: Montebello A, Ricketts W, Druce M,

Keywords: DIPNECH, clinical presentation, diagnosis, longitudinal behaviour,

#3418 Neuroendocrine tumor of the kidney: About an observation

Introduction: Renal neuroendocrine tumors are very rare, with an uncertain prognosis. It is immunostaining with chromogranin A and synaptophysin that confirms the diagnosis.

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Kaid M, Benabdellah H,

Keywords: Renal neuroendocrine tumor, rare, bad prognosis,